Johannes F. Dayrit, MD, FPDS
At the 12th International Congress of Dermatology in Buenos Aires, Dr. Stephen Katz, in his keynote lecture “Molecular Dermatology: Progress and promise”, shared the leading advancements in dermatology. He revealed prospects for gene, protein and stem cell therapy for Recessive Epidermolysis Bullosa, the discovery of BRAF inhibitors that prolong the life of patients with melanoma, and new findings in autoinflammatory diseases and Pharmacogenomics. Ten to fifteen years ago, these major breakthroughs in genetics, molecular biology and targeted therapies would be unimaginable. Their discovery has since significantly impacted the scientific community.